Starna Therapeutics
Latest round
- Series B
Last raised
- May 2026
Total raised
- $114M
Investors
- 7
About Starna Therapeutics
, trading as Starna Therapeutics, specializes in RNA-based drug development technologies and therapies. Its core team consists of professionals from established pharmaceutical companies, universities, and research institutions, with experience in nucleic acid drug discovery, delivery technologies, and formulation development. Starna Therapeutics develops RNA-based therapeutics and drug delivery solutions, built on mRNA technology platforms and lipid nanoparticle (LNP) delivery systems, with capabilities spanning molecule discovery, formulation development, and preclinical research. The company maintains an extensive library of lipid materials and delivery candidates, enabling targeted delivery across multiple organs and tissues, and supports diverse dosage forms including injectable solutions, lyophilized formulations, and inhalable therapies, while advancing a pipeline of mRNA vaccines and therapeutic candidates addressing infectious diseases and other clinical indications. The company generates revenue primarily through the development of RNA-based drug candidates and related technologies, as well as potential collaboration, licensing, and commercialization of its therapeutic pipeline and delivery platforms.
Who invested in Starna Therapeutics
7 investors across 4 rounds
See all investors in Starna Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Starna Therapeutics
Who invested in Starna Therapeutics?
Starna Therapeutics has 7 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Starna Therapeutics raised?
Starna Therapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Starna Therapeutics last raise money?
Starna Therapeutics's most recent round on record is a Series B, in May 2026.
What does Starna Therapeutics do?
, trading as Starna Therapeutics, specializes in RNA-based drug development technologies and therapies.
Where is Starna Therapeutics headquartered?
Starna Therapeutics is headquartered in Suzhou, China.
Which VCs invest in companies like Starna Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Starna Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Starna Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.